The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

Vertex Pharmaceuticals is working toward making its recently approved non-opioid pain medicine Journavx not only broadly ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous Brenton Blanchet is a writer-reporter at PEOPLE. He has been working at PEOPLE ...

The FDA approved Journavx on Thursday following a pair of clinical trials on 874 participants with moderate to severe acute pain following abdominoplasty — commonly known as a "tummy tuck ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...